Showing 2 of 2 recruiting trials for “Rare disorder potentially indicated for transplant or complication after transplantation”
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
👨⚕️ Andreza A Feitosa Ribeiro, PhD, Hospital Israelita Albert Einstein📍 1 site📅 Started Nov 2018View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →